ProfileGDS4718 / 205346_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 45% 44% 45% 47% 39% 44% 46% 45% 37% 39% 44% 41% 39% 48% 42% 42% 41% 55% 37% 34% 42% 37% 48% 46% 41% 44% 46% 41% 39% 41% 55% 37% 48% 41% 48% 43% 38% 43% 43% 56% 41% 40% 44% 48% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.2523445
GSM549102patient 115, normal, homogenized [OPG study]5.1992444
GSM549104patient 119, normal, homogenized [OPG study]5.2606145
GSM549108patient 138, normal, homogenized [OPG study]5.3786447
GSM549119patient 077, normal, homogenized [OPG study]4.9489239
GSM549133patient 032, cancer, homogenized [OPG study]5.1164744
GSM549139patient 042, cancer, homogenized [OPG study]5.2995946
GSM549099patient 107, normal, homogenized [OPG study]5.2731845
GSM549109patient 139, normal, homogenized [OPG study]4.8899537
GSM549110patient 046, normal, homogenized [OPG study]4.9558139
GSM549114patient 063, normal, homogenized [OPG study]5.1589844
GSM549122patient 082, normal, homogenized [OPG study]5.0304241
GSM549134patient 033, cancer, homogenized [OPG study]4.9356639
GSM549136patient 036, cancer, homogenized [OPG study]5.367648
GSM549140patient 044, cancer, homogenized [OPG study]5.0709942
GSM549111patient 047, normal, homogenized [OPG study]5.0874142
GSM549113patient 057, normal, homogenized [OPG study]5.0067241
GSM549132patient 031, cancer, homogenized [OPG study]5.809255
GSM549137patient 038, cancer, homogenized [OPG study]4.8403537
GSM549142patient 047, cancer, homogenized [OPG study]4.8386934
GSM549100patient 110, normal, homogenized [OPG study]5.1403142
GSM549107patient 135, normal, homogenized [OPG study]4.8177137
GSM549115patient 068, normal, homogenized [OPG study]5.3667548
GSM549116patient 072, normal, homogenized [OPG study]5.2618146
GSM549120patient 078, normal, homogenized [OPG study]5.0384741
GSM549131patient 030, cancer, homogenized [OPG study]5.1334344
GSM549118patient 074, normal, homogenized [OPG study]5.2999746
GSM549129patient 027, cancer, homogenized [OPG study]5.0581341
GSM549123patient 088, normal, homogenized [OPG study]4.9305439
GSM549124patient 006, cancer, homogenized [OPG study]5.0991941
GSM549126patient 015, cancer, homogenized [OPG study]5.8097955
GSM549128patient 025, cancer, homogenized [OPG study]4.8357237
GSM549103patient 117, normal, homogenized [OPG study]5.4386848
GSM549117patient 073, normal, homogenized [OPG study]5.0057641
GSM549138patient 041, cancer, homogenized [OPG study]5.3792148
GSM549141patient 045, cancer, homogenized [OPG study]5.0879643
GSM549130patient 028, cancer, homogenized [OPG study]4.9161438
GSM549101patient 111, normal, homogenized [OPG study]5.1803743
GSM549105patient 128, normal, homogenized [OPG study]5.1380543
GSM549106patient 134, normal, homogenized [OPG study]5.8440756
GSM549112patient 048, normal, homogenized [OPG study]5.0342541
GSM549125patient 011, cancer, homogenized [OPG study]4.9851940
GSM549127patient 024, cancer, homogenized [OPG study]5.1758944
GSM549135patient 035, cancer, homogenized [OPG study]5.3865848